Immunohistochemical and biomolecular identification of melatonin 1a and 1b receptors in rat vestibular nuclei

Auris Nasus Larynx

Volumn 39, Issue 5, 2012, Pages 479-483

  Ahn, Seong Ki ^a   Khalmuratova, Roza ^a   Hah, Young Sool ^a   Jeon, Sea Yuong ^a   Hur, Dong Gu ^a   Kang, Hung Soo ^a   Balaban, Carey D ^b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Melatonin receptor; Migraine; Vertigo; Vestibular nuclei

Indexed keywords

MELATONIN 1A RECEPTOR; MELATONIN 1B RECEPTOR; MELATONIN RECEPTOR; MESSENGER RNA; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; BRAIN STEM; CELLULAR DISTRIBUTION; DENDRITE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERIKARYON; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TRIGEMINUS GANGLION; VESTIBULAR NUCLEUS;

ANIMALS; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGEMINAL GANGLION; VESTIBULAR NUCLEI;

EID: 84861917704     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2011.09.007     Document Type: Article

References (25)

1. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991, 12:151-180.
2. Reiter R.J., Oh C.S., Fujimori O., Melatonin: its intracellular and genomic actions. Trends Endcrinol Metab 1996, 7:22-27.
3. Mockus S.M., Vrana K.E. Advances in the molecular characterization of tryptophan hydroxylase. J Mol Neurosci 1998, 10:163-179.
4. Slominski A., Pisarchik A., Zbytek B., Tobin D.J., Kauser S., Wortsman J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 2003, 196:144-153.
5. Peres M.F., Masruha M.R., Zukerman E., Moreira-Filho C.A., Cavalheiro E.A. Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs 2006, 15:367-375.
6. Claustrat B., Loisy C., Brun J., Beorchia S., Arnaud J.L., Chazot G. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 1989, 29:242-245.
7. Murialdo G., Fonzi S., Costelli P., Solinas G.P., Parodi C., Marabini S., et al. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994, 14:205-209.
8. Neuhauser H., Leopold M., von Brevern M., Arnold G., Lempert T. The interrelations of migraine, vertigo and migrainous vertigo. Neurology 2001, 56:436-441.
9. Furman J.M., Marcus D.A., Balaban C.D. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 2003, 16:5-13.
10. Halberstadt A.L., Balaban C.D. Organization of projections from the raphe nuclei to the vestibular nuclei in rats. Neuroscience 2003, 120:571-592.
11. Choi M.A., Lee J.H., Hwang S.J., Choi S.J., Kim M.S., Park B.R. Signaling pathway of glutamate in the vestibular nuclei following acute hypotension in rats. Brain Res 2008, 229:111-117.
12. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1988, Academic Press, San Diego.
13. Johnson G.D. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998, 108:1-28.
14. Koo J.W., Balaban C.D. Serotonin-induced plasma extravasation in the murine inner ear: possible mechanism of migraine-associated inner ear dysfunction. Cephalalgia 2006, 11:1310-1319.
15. Marcus D.A., Furman J.M. Prevention of motion sickness with rizatriptan: a double blind, placebo-controlled pilot study. Med Sci Monit 2006, 12:PI1-PI7.
16. 1F receptor and calcitonin gene-related peptide in rat vestibular nuclei. Neurosci Lett 2009, 465:151-156.
17. Gimeno M.F., Landa A., Sterin-Speziale N., Cardinali D.P., Gimeno A.L. Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus. Eur J Pharmacol 1980, 62:309-317.
18. Nagtegaal J.E., Smits M.G., Swart A.C., Kerkhof G.A., van der Meer Y.G. Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations. Headache 1998, 38:303-307.
19. Li S.R., Wang T., Wang R., Dai X., Chen Q., Li R.D. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice. Brain Res 2005, 1043:132-138.
20. Vogler B., Rapoport A.M., Tepper S.J., Sheftell F., Bigal M.E. Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs 2006, 20:343-350.
21. Peres M.F., Zukerman E., da Cunha Tanuri F., Moreira F.R., Cipolla-Neto J. Melatonin, 3mg, is effective for migraine prevention. Neurology 2004, 63:757.
22. Fraschini F., Cesarani A., Alpini D., Esposti D., Stankov B.M. Melatonin influences human balance. Biol Signals Recept 1999, 8:111-119.
23. Alpini D., Cesarini A., Fraschini F., Kohen-Raz R., Capobianco S., Cornelio F. Aging and vestibular system: specific tests and role of melatonin in cognitive involvement. Arch Gerontol Geriatr Suppl 2004, 9:13-25.
24. Fauteck J.D., Lerchl A., Bergmann M., Moller M., Fraschini F., Wittkowski W., et al. The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing. Neurosci Lett 1994, 179:60-64.
25. Mazzucchelli C., Pannacci M., Nonno R., Lucini V., Fraschini F., Stankov B.M. The melatonin receptor in the human brain: cloning experiments and distribution studies. Mol Brain Res 1996, 39:117-126.